Allspring Global Investments Holdings LLC boosted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 8.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 130,598 shares of the medical instruments supplier’s stock after acquiring an additional 10,352 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.06% of DENTSPLY SIRONA worth $3,701,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Parkside Financial Bank & Trust lifted its position in DENTSPLY SIRONA by 163.7% in the 1st quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier’s stock valued at $46,000 after acquiring an additional 568 shares in the last quarter. Wipfli Financial Advisors LLC bought a new stake in DENTSPLY SIRONA in the 3rd quarter valued at $27,000. Van ECK Associates Corp bought a new stake in DENTSPLY SIRONA in the 2nd quarter valued at $41,000. SJS Investment Consulting Inc. bought a new stake in DENTSPLY SIRONA during the 3rd quarter worth about $35,000. Finally, Wahed Invest LLC bought a new stake in DENTSPLY SIRONA during the 2nd quarter worth about $82,000. 98.52% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several brokerages have commented on XRAY. UBS Group cut their price target on shares of DENTSPLY SIRONA to $35.00 in a research report on Thursday, November 17th. Barrington Research cut their price target on shares of DENTSPLY SIRONA from $51.00 to $40.00 in a research report on Tuesday, November 15th. StockNews.com began coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, October 12th. They set a “hold” rating on the stock. The Goldman Sachs Group cut their price target on shares of DENTSPLY SIRONA from $41.00 to $34.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 16th. Finally, Piper Sandler cut their price target on shares of DENTSPLY SIRONA from $38.00 to $29.00 in a research report on Monday, November 14th. Seven investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $40.70.
DENTSPLY SIRONA Stock Performance
DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last announced its quarterly earnings results on Monday, November 14th. The medical instruments supplier reported $0.41 EPS for the quarter, missing analysts’ consensus estimates of $0.59 by ($0.18). DENTSPLY SIRONA had a negative net margin of 20.81% and a positive return on equity of 9.63%. The company had revenue of $947.00 million during the quarter, compared to analyst estimates of $1.01 billion. During the same quarter last year, the company posted $0.68 EPS. The firm’s quarterly revenue was down 8.9% on a year-over-year basis. Sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 1.96 EPS for the current fiscal year.
DENTSPLY SIRONA Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, January 13th. Investors of record on Friday, December 30th were paid a $0.125 dividend. The ex-dividend date was Thursday, December 29th. This represents a $0.50 dividend on an annualized basis and a yield of 1.36%.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.
- Get a free copy of the StockNews.com research report on DENTSPLY SIRONA (XRAY)
- Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
- Can Alaska Air Continue Soaring Above The Airline Industry?
- Insulet Has Potential To Gain More Than Analysts Are Forecasting
- Cathie Wood Is Buying These Stocks, Should You?
- Thor Industries Hammered Its Numbers. Is it a Buy?
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.